Is a complete HUMA research report available?

No complete published report is available for Humacyte, Inc. (HUMA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Humacyte, Inc. (HUMA)

NASDAQ: HUMA · USD

$0.62

-0.01 (-2.2%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-26 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first HUMA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	168.5M
Revenue (ttm)	2M
Net income (ttm)	-95.2M
EPS (ttm)	-$0.55
Shares out	269.6M
Volume	2,566,399
Beta	2.52
Price target	$2.05	+228.1%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2M
Net income (ttm): -95.2M
EPS (ttm): -$0.55
Market cap: 168.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All HUMA indicators

Market & fundamental data

Available fields

204

Groups with data

Currency

USD

Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001818382
Company name	Humacyte, Inc.
Country	United States
Country code	US
Cusip	44486Q103
Employees	184
Employees Change	-36%
Employees Change Percent	-16.36
Enterprise value	$186.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US44486Q1031
Last refreshed	2026-07-26
Market cap	$168.5M
Market cap category	Micro-Cap
Price	$0.62
Price currency	USD
Rev Per Employee	10,956.52x
Sector	Healthcare
Sector PE	44.87
Sector PE Fwd	23.76
Sic	2836
Symbol	HUMA
Website	https://www.humacyte.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-56.52%
EV Sales Forward	21.19x
EV/Sales	92.48x
FCF yield	-60.77%
P/B ratio	11.93x
P/S ratio	83.57x
PS Forward	19.15x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-5,649.21%
EBITDA Margin	-5,286.95%
Gross Profit	$-81.7M
Net Income	$-95.2M
Net Income Growth Years	1%
Pretax Margin	-4,840.82%
Profit Per Employee	$-517,484
ROA	-51.48
Roa5y	-38.07
ROCE	-120.7
ROE	-409.5
ROIC	-71.49

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-77.14%
Cagr3y	-40.65%
Cagr5y	-42.56%
EPS Growth Years	1
Revenue Growth	289.94x
Revenue Growth Q	-4.26x
Revenue Growth Years	0x
Revenue Growth3 Y	14.81x
Revenue Growth5 Y	7.7x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.01
Assets	$110.6M
Cash	$48.5M
Current Assets	$63.6M
Current Liabilities	$16.2M
Debt	$66.5M
Debt Equity	$5.72
Equity	$11.6M
Interest Coverage	-10.82
Liabilities	$98.9M
Long Term Assets	$47M
Long Term Liabilities	$82.7M
Net Cash	$-18M
Net Cash By Market Cap	$-10.66
Net Debt Equity	$1.55
Tangible Book Value	$11.6M
Tangible Book Value Per Share	$0.05
WACC	16.51

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.93
Inventory Turnover	9.34
Net Working Capital	$1.3M
Quick ratio	3.03
Working Capital	$47.4M
Working Capital Turnover	$0.04

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-40.6%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-77.11%
200-day SMA	1.08
3Y total return	-79.1%
50-day SMA	0.94
50-day SMA vs 200-day SMA	50under200
5Y total return	-93.75%
All Time High	17.45
All Time High Change	-96.42%
All Time High Date	2021-09-01
All Time Low	0.55
All Time Low Change	14.24%
All Time Low Date	2026-03-30
ATR	0.07
Beta	2.52
Beta1y	3.79
Beta2y	2.96
Ch YTD	-34.95
High	0.65
High52	2.76
High52 Date	2025-08-08
High52ch	-77.32%
Low	0.62
Low52	0.55
Low52 Date	2026-03-30
Low52ch	14.24%
Ma50ch	-33.2%
Premarket Change Percent	0.67
Premarket Price	$0.64
Premarket Volume	79,742
Price vs 200-day SMA	-41.88%
RSI	34.89
RSI Monthly	39.96
RSI Weekly	38.31
Sharpe ratio	-0.75x
Sortino ratio	-0.99
Total Return	-40.6%
Tr YTD	-34.95
Tr1m	-10.79%
Tr1w	-6%
Tr3m	-11.76%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	2
Analyst Price Target Top	$2.5
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.1
Earnings Revenue Estimate	1,168,240x
Earnings Revenue Estimate Growth	288.12x
Operating Income	$-112.5M
Operating margin	-5,579.8
Price target	$2.05
Price Target Change	$228
Price Target Change Top	$300

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	238,193,833%
Float Percent	88.34%
Net Borrowing	37,671,000
Shares Insiders	3.61%
Shares Institutions	27.02%
Shares Out	269,638,156
Shares Qo Q	5.92%
Shares Yo Y	40.6%
Short Float	13.27%
Short Ratio	1.87
Short Shares	11.72

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-112.8M
Average Volume	11,774,212.7x
Bv Per Share	0.05
CAPEX	$-831,000
Ch1m	-10.79
Ch1w	-6
Ch1y	-77.11
Ch3m	-11.76
Ch3y	-79.1
Ch5y	-93.75
Ch6m	-40.5
Change	-2.16%
Change From Open	-3.03
Close	0.64
Days Gap	0.89
Depreciation Amortization	7,303,000
Dollar Volume	1,603,486.1
Earnings Date	2026-08-10
Earnings Time	bmo
EBIT	$-113.9M
EBITDA	$-106.6M
EPS	$-0.55
F Score	4
FCF	$-102.4M
FCF EV Yield	-54.91x
FCF Per Share	$-0.38
Financing CF	38,068,000
Fiscal Year End	December
Founded	2,004
Investing CF	-831,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-13
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-27
Ma150	0.95
Ma150ch	-34.54%
Ma20	0.7
Ma20ch	-10.6%
Net CF	-64,308,000
Next Earnings Date	2026-08-10
Open	0.64
Optionable	Yes
Position In Range	13.7
Post Close	0.62
Postmarket Change Percent	-0.05
Postmarket Price	$0.62
Ppne	46,079,000
Pre Close	0.64
Price Date	2026-07-24
Ptbv Ratio	14.49
Relative Volume	0.22x
Revenue	2,016,000x
SBC By Revenue	517.66x
Share Based Comp	10,436,000
Tr6m	-40.5%
Us State	North Carolina
Volume	2,566,399
Z Score	-10.63

Humacyte, Inc. (HUMA)

Coverage state: Market snapshot only — no published research

Generate the first HUMA analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · HUMA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All HUMA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on HUMA

Frequently asked questions